Testolactone

Testolactone

Clinical data
Routes of administration	Oral
Pharmacokinetic data
Protein binding	~85%
Metabolism	Hepatic
Excretion	Renal
Identifiers
IUPAC name (4aS,4bR,10aR,10bS,12aS)-10a,12a-Dimethyl-4,4a,4b,5,6,10b,11,12-octahydro-3H-naphtho[6,5-f]chromene-2,8-dione
CAS Number	968-93-4
PubChem CID	13769
DrugBank	DB00894
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C19H24O3
Molar mass	300.39 g/mol
3D model (JSmol)	Interactive image
SMILES CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C

WikiDoc Resources for Testolactone
Articles
Most recent articles on Testolactone Most cited articles on Testolactone Review articles on Testolactone Articles on Testolactone in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Testolactone Images of Testolactone Photos of Testolactone Podcasts & MP3s on Testolactone Videos on Testolactone
Evidence Based Medicine
Cochrane Collaboration on Testolactone Bandolier on Testolactone TRIP on Testolactone
Clinical Trials
Ongoing Trials on Testolactone at Clinical Trials.gov Trial results on Testolactone Clinical Trials on Testolactone at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Testolactone NICE Guidance on Testolactone NHS PRODIGY Guidance FDA on Testolactone CDC on Testolactone
Books
Books on Testolactone
News
Testolactone in the news Be alerted to news on Testolactone News trends on Testolactone
Commentary
Blogs on Testolactone
Definitions
Definitions of Testolactone
Patient Resources / Community
Patient resources on Testolactone Discussion groups on Testolactone Patient Handouts on Testolactone Directions to Hospitals Treating Testolactone Risk calculators and risk factors for Testolactone
Healthcare Provider Resources
Symptoms of Testolactone Causes & Risk Factors for Testolactone Diagnostic studies for Testolactone Treatment of Testolactone
Continuing Medical Education (CME)
CME Programs on Testolactone
International
Testolactone en Espanol Testolactone en Francais
Business
Testolactone in the Marketplace Patents on Testolactone
Experimental / Informatics
List of terms related to Testolactone

Overview

Testolactone, or Teslac (brand name) is an antineoplastic agent that is a derivative of progesterone and is used to treat advanced stage breast cancer.

Pharmacology

Testolactone is a synthetic antineoplastic agent that is structurally distinct from the androgen steroid nucleus in possessing a six-membered lactone ring in place of the usual five-membered carbocyclic D-ring. Despite some similarity to testosterone, testolactone has no in vivo androgenic effect. No other hormonal effects have been reported in clinical studies in patients receiving testolactone.

Mechanism of Action

The principal action of testolactone is reported to be inhibition of steroid aromatase activity and the reduction in estrone synthesis that fallows. Androstenedione, a 19-carbon steroid hormone produced in the adrenal glands and the gonads, is where estrone synthesis originates and is the source of estrogen in postmenopausal women. In vitro studies report that the aromatase inhibition may be noncompetitive and irreversible, and could possibly account for the persistence of this drug's effect on estrogen synthesis after drug withdrawal.

Uses

This drug is mainly used for treating various types of breast cancer in women who have been through menopause or whose ovaries no longer function. It works by blocking the production of estrogen, which helps prevent the growth of breast cancers that are activated by estrogen. It may also prevent tumor cells from being activated by other hormones.

Side effects

The most COMMON side effects include:

• Abnormal skin sensations
• Aches of the legs and arms
• General body discomfort
• Hair loss
• Loss of appetite
• Nausea
• Redness of the tongue
• Vomiting